Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis.

CONCLUSIONS: The overall costs of chemotherapy for patients diagnosed with castration resistant prostate cancer in Japan are high. Our findings can serve as a basis for health economic evaluations. PMID: 29625534 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research